Assessing agreement in the timing of treatment initiation determined by repeated measurements of novel versus gold standard technologies with application to the monitoring of CD4 counts in HIV-infected patients

Statistics in Medicine

Volumn 29, Issue 18, 2010, Pages 1932-1946

  Noubary, Farzad ^a   Hughes, Michael D ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bias; Confirmatory measurement; Diagnostic testing; Error; Time to threshold

Indexed keywords

BIOLOGICAL MARKER; ZIDOVUDINE;

ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL DECISION MAKING; DISEASE COURSE; FLOW CYTOMETRY; GOLD STANDARD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; RISK ASSESSMENT; SIMULATION; STANDARD; STATISTICAL MODEL; TECHNOLOGY;

BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; DIAGNOSTIC TESTS, ROUTINE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MONITORING, PHYSIOLOGIC; TIME FACTORS;

EID: 77955357335     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3955     Document Type: Article

References (23)

1. WHO. Antiretroviral Therapy for HIV infection in Adults and Adolescents: Recommendations for a Public Health Approach. WHO, Geneva, Switzerland. August 7, 2006, Available at: http://www.who.int/entity/hiv/pub/guidelines/ artadultguidelines.pdf, Accessed December 3, 2009.
2. WHO. Rapid Advice: Antiretroviral Therapy for HIV Infection in Adults and Adolescents. WHO, Geneva, Switzerland. November 30, 2009, Available at: http://www.who.int/hiv/pub/arv/rapid-advice-art.pdf, Accessed December 3, 2009.
3. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents. Department of Health and Human Services, Washington DC, U.S.A. December 1, 2009, Available at: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL. pdf, Accessed December 3, 2009.
4. Rodriguez W, Christodoulides N, Floriano P, Graham S, Mohanty S, Dixon M, Hsiang M, Peter T, Zavahir S, Thior I. A microchip CD4 counting method for HIV monitoring in resource-poor settings. PLoS Medicine 2005; 2(7):e182.
5. Forum for Collaborative HIV Research. Transfer of HIV Monitoring Technologies into Resource-poor Settings: Moving the Field Forward. February 26, 2005, Available at: http://www.hivforum.org/storage/hivforum/documents/ Febeport.pdf, Accessed April 10, 2009.
6. Mandy F, Janossy G, Bergeron M, Pilon R, Faucher S. Affordable CD4 T-Cell enumeration for resource-limited regions: a status report for 2008. Cytometry Part B (Clinical Cytometry) 2008; 74(1):S27-S39.
7. Spacek L, Shihab H, Lutwama F, Summerton J, Mayanja H, Ronald A, Margolick J, Nilles T, Quinn T. Evaluation of a low-cost method, the Guava EasyCD4 Assay, to enumerate CD4-positive lymphocyte counts in HIV-infected patients in the United States and Uganda. Journal of Acquired Immune Deficiency Syndromes 2006; 41(5):607-610.
8. Srithanaviboonchai K, Rungruengthanakit K, Nouanthong P, Pata S, Sirisanthana T, Kasinrerk W. Novel low-cost assay for the monitoring of CD4 counts in HIV-infected individuals. Journal of Acquired Immune Deficiency Syndromes 2008; 47(2):135-139.
9. Bland J, Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet 1986; 1(8476):307-310.
10. Madec Y, Japhet C. First passage time problem for a drifted Ornstein-Uhlenbeck process. Mathematical Biosciences 2004; 189(2):131-140.
11. Multicenter AIDS Cohort Study (MACS) Public Dataset: Release PO4.: National Technical Information Service:Springfield, VA, 1995. Available at: http://www.statepi.jhsph.edu/macs/pdt.html, Accessed September 14, 2009.
12. Kaslow R, Ostrow D, Detels R, Phair J, Polk B, Rinaldo Jr C. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. American Journal of Epidemiology 1987; 126(2):310-318.
13. Boscardin W, Taylor J, Law N. Longitudinal models for AIDS marker data. Statistical Methods in Medical Research 1998; 7(1):13-27.
14. Taylor J, Cumberland W, Sy J. A stochastic model for analysis of longitudinal AIDS data. Journal of the American Statistical Association 1994; 89(427):727-736.
15. Zhang D, Lin X, Raz J, Sowers M. Semiparametric stochastic mixed models for longitudinal data. Journal of the American Statistical Association 1998; 93(442):710-719.
16. Fitzmaurice G, Laird N, Ware J. Applied Longitudinal Analysis. Wiley: Berlin, 2004.
17. Berman S. A stochastic model for the distribution of HIV latency time based on T4 counts. Biometrika 1990; 77(4):733-741.
18. Braithwaite R, Roberts M, Chang C, Goetz M, Gibert C, Rodriguez-Barradas M, Shechter S, Schaefer A, Nucifora K, Koppenhaver R et al. Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model. Annals of Internal Medicine 2008; 148(3):178-185.
19. Kitahata M, Gange S, Abraham A, Merriman B, Saag M, Justice A, Hogg R, Deeks S, Eron J, Brooks J et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. New England Journal of Medicine 2009; 360:1-12.
20. Diggle P. Testing for random dropouts in repeated measurement data. Biometrics 1989; 45(4):1255-1258.
21. Ridout M. Reader reaction: testing for random dropouts in repeated measurement data. Biometrics 1991; 47(4):1617-1621.
22. Phillips A, Pezzotti P. Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era. AIDS 2004; 18(1):51-58.
23. Fine J, Jiang H, Chappell R. On semi-competing risks data. Biometrika 2001; 88(4):907-919.